System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giuseppe Boccadifuoco is an expert in Immunology at VisMederi (Italy) (Italy). Giuseppe Boccadifuoco has authored 14 publications, the most recent in 2021. SLR score: 24 (community average: 125). How the SLR is computed.

LeadR Profile

Giuseppe Boccadifuoco VisMederi (Italy) Italy
24 ScienceLeadR Reputation 24

Unlock

Register Login
Network Map

Immunology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2021
Source: PubMed

GlaxoSmithKline (Italy)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 14

Citations

Citations: 876 1st author: 2 Last author: 0 Unique author: 0

Main journals

mSphere 3
Hum Vaccin Immunother 2
Clin Vaccine Immunol 1
Infect Immun 1
J Immunol Res 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France.
PMID 34856875 — whole genome sequencing, serogroup, vaccines, alleles		Hum Vaccin Immunother202113
High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.
PMID 33847225 — serogroup, vaccines		Hum Vaccin Immunother202114
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Strains and Their Predicted Coverage by the 4CMenB Vaccine.
PMID 32132156 — aged, microbiological phenomena, vaccines, meningococcal infections, molecular epidemiology, serogroup		mSphere202013
Meningococcal Antigen Typing System (MATS): A Tool to Estimate Global Coverage for 4CMenB, a Multicomponent Meningococcal B Vaccine.
PMID 30877679 — vaccines, enzyme-linked immunosorbent assay		Methods Mol Biol20199
Erratum for Rajam et al., "Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States".
PMID 31189561 — microbiological phenomena, vaccines, neisseria meningitidis, serogroup		mSphere20190

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS